FR001400K4B1

PHAXIAM Presented its IVD Phagogram test and updated phage susceptibility tracking at the first “Phagogram Day”

PHAXIAM Presented its IVD Phagogram test and updated phage susceptibility tracking at the first "Phagogram Day" This event, organized in…

1 month ago

PHAXIAM Reports Third-Quarter 2024 Financial Information

Cash and cash equivalents of €5.7 million as of September 30, 2024Execution of clinical strategy as planned, with the GLORIA…

1 month ago

Monthly information related to total number of voting rights and shares composing the share capital October 31, 2024

Monthly information related to total number of voting rights and shares composing the share capital – October 31, 2024 Article…

2 months ago